*001983650
*00520231016112907.0
*007ta
*008141204s2004    no            000 0 eng
*00901353cam a2200361 c 4500
*015  $a0506232$2nbf
*019  $bl
*020  $a8275891507$qh.
*035  $a(EXLNZ-47BIBSYS_NETWORK)990500195464702201
*035  $a(NO-LaBS)14351273(bibid)
*035  $a(NO-TrBIB)050019546
*035  $a050019546-47bibsys_network
*040  $aNO-OsNB$bnob$ekatreg
*042  $anorbibl
*044  $cno
*060 4$aQW 165.5.H3
*08274$a616.019$qNO-OsNB$25/nor
*1001 $aJenssen, Håvard$d1974-$0(NO-TrBIB)47928$_246700900
*24510$aAntiviral mode of action of lactoferrin and lactoferricin :$ba model system for design of antiviral peptides with enhanced activity towards Herpes simplex virus$cHåvard Jenssen
*260  $a[Tromsø]$bDepartment of Microbiology, University Hospital of North Norway$bDepartment of Microbiology and Virology, University of Tromsø$c2004
*300  $a1 b. (flere pag.)$bill.
*500  $aDelvis opptrykk av artikler
*502  $aAvhandling (dr. scient.) - Universitetet i Tromsø, 2004.
*650 2$aAntiviral Agents$xpharmacology$_122956400
*650 2$aCell Membrane$xchemistry$_122956500
*650 2$aHerpesvirus 1, Human$xpathogenicity$_122956600
*650 2$aHerpesvirus 2, Human$xpathogenicity$_122956700
*650 2$aLactoferrin$xpharmacology$_31703800
*7102 $aUniversitetet i Tromsø$4dgg$_13228400
*901  $a90
*913  $aNorbok$bNB
*917  $ad
*999  $aoai:nb.bibsys.no:990500195464702202$b2021-11-14T21:13:22Z$z990500195464702202
^